5 Undervalued Health Care Providers & Services Stocks for Tuesday, August 25
Discover the top 5 undervalued Health Care Providers & Services stocks for Tuesday, August 25 based on AAII’s Stock Grades.Tudor Pop
Stock Evaluator: Cardinal Health, Inc. (CAH)
688 followersCardinal Health, Inc. CAH
$252.65
-1.41
-0.55%
October 19, 2026 4:00:02 PM
EST
Volume: 3,781,609
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Commentary & Analysis
Why Cardinal Health, Inc.’s (CAH) Stock Is Up 7.62%
As of Tuesday, August 11, Cardinal Health, Inc.’s CAH share price has surged by 7.62%, which has investors questioning if this is right time to sell.Jenna Brashear
What You Need to Know About Cardinal Health, Inc.'s Q1 Earnings
Cardinal Health, Inc.'s fiscal Q1 earnings report was released on Tuesday, August 11. Let's dive in to see if (CAH) missed or beat analyst's expectations.Jenna Brashear
3 Undervalued Health Care Providers & Services Stocks for Wednesday, July 22
Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, July 22 based on AAII’s Stock Grades.Michael Rose
Which Is a Better Investment, Cardinal Health, Inc. or Henry Schein, Inc. Stock?
Learn more about whether Cardinal Health, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Financial Summary
| Share Statistics | CAH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $58,503.5 | $1,695.7 | 94% |
|
| Shares Out (Mil) | 235.0 | 81.4 | 79% |
|
| Institutional Ownership | 99.9% | 86.9% | 96% |
|
| Float (Mil) | 231.0 | 56.2 | 76% |
|
| Beta | 0.50 | 0.78 | 28% |
|
| Avg Daily Volume (000s) | 1,581 | 565 | 78% |
|
| Price Change (52-week) |
64.8% | 77.3% | 90% |
|
| Growth | CAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 9.4% | 10.6% | 56% |
|
| Net Income (5yr) | 22.9% | (0.7%) | 77% |
|
| EPS (5yr) | 28.3% | 1.2% | 79 |
|
| Dividends (5yr) | 1.1% | 0.0% | 90% |
|
| Cash Flow (5yr) | 10.3% | (17.3%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 17 | 17 | |
| Current EPS | $2.939 | $12.565 | $14.059 | |
| Month Ago EPS | $2.937 | $12.567 | $14.077 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $2.904 | $12.066 | $13.557 | |
| Year/Year Chg | 74.8% | 73.8% | 115.6% | |
| Financials | CAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $254,248 | $1,505 | 100% |
|
| Net Income (TTM) (Mil) | $1,714 | $26 | 91% |
|
| EPS (TTM) | $7.263 | $0.200 | 91% |
|
| Operating Cash Flow (TTM) (Mil) | $5,174 | $165 | 95% |
|
| Net Cash Flow (TTM) (Mil) | $982 | $2 | 94% |
|
| Long-Term Debt (Q1) (Mil) | $7,915 | $394 | 90% |
|
| Enterprise Value (Q1) (Mil) | $64,131 | $2,284 | 94% |
|
| Valuation | CAH | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.88 | na |
|
| P/E | 34.9 | 26.5 | 77% |
|
| Dividend Yield | 0.8% | 0.0% | 65% |
|
| PEG (5yr hist) | 1.2 | 1.1 | 55% |
|
| Ratios | CAH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 3.8% | 27.0% | 6% |
|
| Net Margin | 0.7% | 1.2% | 33% |
|
| ROA | 3.1% | 2.1% | 62% |
|
| ROE | (60.5%) | 6.9% | 13% |
|
| Liabilities to Assets | 104.8% | 61.3% | 95% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 10/19/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
O'Neil's CAN SLIM No Float Screen
Factors: Momentum, Growth
An approach that combines both fundamental and technical factors to seek out companies with strong earnings and price momentum.
| Performance Since Inception: | 12.7% |
| +/- S&P 500: | +5.2 |
